We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

129 hedge funds and large institutions have $31.1M invested in SANGAMO THERAPEUTICS INC in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 44 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 28

2% less funds holding

Funds holding: 131 → 129 (-2)

7.71% less ownership

Funds ownership: 49.58% → 41.88% (-7.7%)

25% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 44

52% less call options, than puts

Call options by funds: $29K | Put options by funds: $60K

54% less capital invested

Capital invested by funds: $68.2M → $31.1M (-$37.1M)

Holders
129
Holders Change
-2
Holders Change %
-1.53%
% of All Funds
1.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
33
Reduced
44
Closed
28
Calls
$29K
Puts
$60K
Net Calls
-$31K
Net Calls Change
+$44K

Top Buyers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.49M
2
Renaissance Technologies
Renaissance Technologies
New York
+$826K
3
Millennium Management
Millennium Management
New York
+$704K
4
YIH
Y-Intercept (HK)
Hong Kong
+$402K
5
Goldman Sachs
Goldman Sachs
New York
+$379K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$4.63M
2
AC
Armistice Capital
New York
-$1.57M
3
State Street
State Street
Massachusetts
-$1.21M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.03M
5
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$839K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
101
Osaic Holdings
Arizona
$2.13K -$1.96K -3,630 -38%
BL
102
BFSG LLC
California
$1.31K – – –
JP Morgan Chase
103
JP Morgan Chase
New York
$1.15K -$713K -1,319,341 -100%
Optiver Holding
104
Optiver Holding
Netherlands
$1.15K +$1.73K +3,200 New
BNP Paribas Financial Markets
105
BNP Paribas Financial Markets
France
$1.11K -$37.3K -69,054 -96%
RWMG
106
Redwood Wealth Management Group
New Jersey
$1.07K +$1.62K +3,000 New
Carson Wealth (CWM LLC)
107
Carson Wealth (CWM LLC)
Nebraska
$1K +$751 +1,390 +23,167%
AF
108
Advisornet Financial
Minnesota
$747 – – –
BLC
109
Brown, Lisle/Cummings
Rhode Island
$546 +$824 +1,525 New
New York State Common Retirement Fund
110
New York State Common Retirement Fund
New York
$479 -$20.9K -38,653 -97%
AF
111
Allworth Financial
California
$398 -$269 -497 -33%
PNC Financial Services Group
112
PNC Financial Services Group
Pennsylvania
$386 -$67 -124 -10%
HNB
113
Huntington National Bank
Ohio
$372 +$23 +43 +4%
SPIA
114
Steward Partners Investment Advisory
New York
$358 – – –
AWM
115
Activest Wealth Management
Florida
$358 +$540 +1,000 New
CIBC Private Wealth Group
116
CIBC Private Wealth Group
Georgia
$318 – – –
US Bancorp
117
US Bancorp
Minnesota
$192 +$289 +535 New
VWM
118
Venturi Wealth Management
Texas
$180 – – –
GRP
119
Global Retirement Partners
California
$176 – – –
AFWM
120
Abich Financial Wealth Management
Virginia
$150 +$226 +418 New
SSB
121
Sandy Spring Bank
Maryland
$144 +$216 +400 New
AFG
122
Albion Financial Group
Utah
$72 – – –
CAS
123
Coppell Advisory Solutions
Texas
$72 +$108 +200 New
National Bank of Canada
124
National Bank of Canada
Quebec, Canada
$67 – – –
AAP
125
Arax Advisory Partners
Colorado
$51 +$77 +142 New
3 4
5
6 7

SGMO Hedge Fund Activity: Q2 2024 in Review

129 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2024, worth a combined $31.1M — down 54% from $68.2M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of SGMO and 26 opened new positions — a net loss of 2 holders — while 44 trimmed existing stakes and 33 added.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $1.49M. The largest seller was BlackRock, cutting an estimated $4.63M.

  • 129 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2024, down from 131 in Q1 2024.
  • Funds reported $31.1M of SANGAMO THERAPEUTICS INC stock for Q2 2024, down 54% quarter-over-quarter.
  • 26 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2024 and 28 closed out, a net change of -2 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2024 was Jacobs Levy Equity Management, an estimated $1.49M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2024 was BlackRock, an estimated $4.63M sold.

Based on aggregated 13F filings for Q2 2024.